Tackling Toxicity Studies & Moving Lead Candidates to the Clinic for Myasthenia Gravis
Time: 3:45 pm
day: Conference Day One
Details:
- Highlighting the unique safety risks of the different antigen-specific approaches
- Discussing the toxicity studies for lead candidates to accelerate to the clinic
- Showcasing the data from toxicity studies in tolerance for autoimmune diseases
- Divulging regulatory discussions to illuminate progressing the tolerance landscape and approaches forward
